At ACR Convergence 2025, researchers from Toronto and NYU reported that PsA patients starting GLP-1 receptor agonists had significant improvements in joint counts, CRP, pain scores, and DAPSA disease activity scores within one year of treatment. Whats interesting is that you dont seem to need a large dose to see these benefits
GIP and GLP-1 may exert long-term effects on -cell survival and proliferation, potentially delaying the development of and even reversing T2DM
With Ozempic injection, the insulin secretion rate in patients with type 2 diabetes was similar to that of healthy subjects
Not to mention: the astronomical cost of medical services and medication
Semaglutide's data are built on over 25,000 participants across more than 20 randomized controlled trials, including the largest cardiovascular outcomes trial ever conducted for an anti-obesity medication
NAION typically causes sudden, painless vision loss in one eye and may result in permanent visual impairment, blind spots, reduced peripheral vision, or loss of visual clarity